Navigation Links
Obesity Surgery Complication Rates Higher than Previously Thought

Four of every 10 obesity surgery patients develop a complication, such as a hernia, within 6 months of leaving the hospital, according to a new study by HHS’ Agency// for Healthcare Research and Quality. The study is the most extensive to date on post-surgical complications from obesity operations based on insurance claims data.

The researchers found that the complication rate among non-elderly obesity surgery patients with private insurance increased by 81 percent following hospital discharge – from 21.9 percent while they were still hospitalized to 39.6 percent by the end of the 180-day study period.

“Obesity surgery is helping thousands of Americans who have not succeeded at losing weight reduce their risk of diabetes and other life-threatening diseases, but this study shows how important it is for patients to consider the potential complications when they make the decision to undergo the procedure,” said AHRQ Director Carolyn M. Clancy, M.D. “The study also should give clinicians information that will help them make improvements in the procedure and post-surgical care.”

The five most common complications were dumping syndrome, which includes vomiting, reflux, and diarrhea (nearly 20 percent); anastomosis complications (complications resulting from the surgical joining of the intestine and stomach), such as leaks or strictures (12 percent); abdominal hernias (7 percent); infections (6 percent); and pneumonia (4 percent). The overall death rate for entire the 180-day postoperative period studied was low – 0.2 percent.

Complications from obesity surgery also increased costs. Medical care spending averaged $36,542 for obesity surgery patients who experienced a complication up to 180 days after surgery, including their initial hospital stay; spending for patients without complications averaged $25,337. In addition, medical care spending for patients who had to be readmitted because of a complication during the 180-day
'"/>




Page: 1 2

Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Obesity raises IVF miscarriage risk
3. Obesity a risk for pancreatic cancer
4. Obesity shortens lifespan
5. Is Obesity a risk factor?
6. Obesity a global problem
7. Obesity increases health costs
8. Obesity in children a risk factor for diabetes
9. Decrease of Hunger Hormone after Obesity Surgery
10. Obesity risk for immobilized adults
11. Obesity risk can be reduced by eating breakfast regularly
Post Your Comments:
(Date:7/9/2008)...sts.com, a leader in online insurance data and fre...rehensive information to help voters understand th...ealth reform as election 2008 nears. The site, whi...al on medical, auto, homeowners, and life insuranc... in coverage for themselves and their families. ,...
(Date:7/8/2008)...through adolescence may experience unhealthy level... always clear. In fact, many potential causes of ...on to be published in The Journal of Pediatrics ...alcohol and coffee consumption on weight gain in a...lleagues from Harvard Medical School, Brigham & Wo...
(Date:7/8/2008)...ly to develop disease , , TUESDAY, July...els of iron in men with peripheral arterial diseas...cording to a new study. , Lower levels of iron ...wer cancer incidence in observational studies. ,...d trial of men with peripheral arterial disease le...
(Date:7/8/2008)...Delays in Oxygen Orders, Lack of,Trained Technicia.../ -- The new Medicare,competitive bidding program ...and chaos for beneficiaries, physicians, hospital ...oviders across the country since it,was implemente...g program has triggered widespread disruptions in ...
Breaking Medicine News(10 mins):Health News:InsuranceSpecialists.com Looks at the Candidates and Health Reform 2Health News:InsuranceSpecialists.com Looks at the Candidates and Health Reform 3Health News:The Internet, alcohol and sleep 2Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 2Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 3Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 4Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 5
...aper on chronic obstructive pulmonary disease (COP...re often useful for patients of this disease to ha...c obstructive pulmonary disease (COPD) are lung di...d conditions like lung tissue destruction, airway ...
...e recent issue of the journal Thorax, researchers ...moking. Researchers have looked into the data prov...a firm connection between smoking and incidence of...subjects about 76% of them tested positive for tub...
...d a final guidance titled "Pharmacogenomic Data Su...roducts through the science of pharmacogenomics. P...entify sources of an individual's profile of drug ...le treatment option for this individual. This tech...
...nt component of mammal’s daily life and more so of...tation are known to sleep for over 18 hours. Howev...g in the sea. It has been reported in Nature that ...e wake most of the time in the first month. Their ...
Other Medicine News:Health News:Advent of New, More Effective and Personalized Medicines 2
(Date:7/7/2008)... Expanded HCV Development Presence Includes ANA598...tentially Complementary Mechanisms ..., July 7 /- Anadys Pharmace...t it is resuming clinical,investigation of the Tol...nt of chronic hepatitis C. Based on preclinical ph...
(Date:7/7/2008)... HONG KONG, July 7 /- OrbusNeich to...17th Annual Meeting of the Japanese Society of,Int... Bio-engineered R,stent has better outcomes when c...erico Piscione, M.D., the study,s principal,invest...sity of Naples,s,Division of Cardiology, Departmen...
(Date:7/6/2008)...Results are basis for CTI,s Marketing Authorizatio...er review by the EMEA, SEATTLE, July 7 /PRNewswir...daq: CTIC ; MTA) today announced the publication ...paring OPAXIO(TM) (paclitaxel poliglumex,CT-2103)... of PS 2,(performance status 2) patients with prev...
(Date:7/2/2008)... - Top-line Data Expected in Aug...-- Isolagen(TM), Inc. (Amex:,ILE) announced today ...its,Phase III clinical studies (IT-R-005/006) inve...nt of nasolabial folds, or wrinkles. The last,pers...y follow-up visit,and collation of this data has ...
Breaking Medicine Technology:Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 2Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 3Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 4Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 5Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents 2Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 4Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 5Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles 2Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles 3Researchers discover molecular basis of a form of muscular dystrophy 3111 1Researchers discover molecular basis of a form of muscular dystrophy 3111 2LMS CALM 28R 29 receives high customer satisfaction scores in the 2008 KLAS Labor and Delivery report 17995 1LMS CALM 28R 29 receives high customer satisfaction scores in the 2008 KLAS Labor and Delivery report 17995 2LMS CALM 28R 29 receives high customer satisfaction scores in the 2008 KLAS Labor and Delivery report 17995 3BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology 17991 1BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology 17991 2BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology 17991 3BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology 17991 4BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology 17991 5Botaneco signs feasibility agreement with Croda to develop specialty crop oil formulation 4969 1Botaneco signs feasibility agreement with Croda to develop specialty crop oil formulation 4969 2Botaneco signs feasibility agreement with Croda to develop specialty crop oil formulation 4969 3
...nsive Survey Provides New Benchmark on MRSA,in Hea...ewswire-USNewswire/ -- The,following was released ...ide study of the prevalence of Methicillin-resista...t multi-drug resistant organism, in U.S. h...dy findings significantly exceed previous estimate...
...(June 21, 2007) Nymox Pharmaceutical,Corporation (...s,from the Company’s recently completed stud...PH) will be presented at a series of,upcoming U.S....outh,Central American Urological Association Meeti...resentations will be given by,leading clinical res...
Other Medicine Technology:Nationwide MRSA Prevalence Study to Demonstrate Full Scope of,'Superbug' Threat Facing U.S. Healthcare Facilities and Patients 2Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S.,Urology Meetings 2Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S.,Urology Meetings 3
...t immunoassay system built around the many positiv...rtant addition of Logic Driven Incubation (LDI). L...optimal performance with the fastest possible incu...uch as the cardiac biomarkers and HCG to be run in...
For The Detection Of Serum C-Peptide Levels.,Clinical Uses Of C-Peptide Measurement:, Evaluating patients with fasting hypoglycemia , Assisting in the classification of diabetes mellitus , D
Measles IgG ELISA test system is designed for the qualitative detection of IgG antibodies to Measles (Rubeola) virus in human serum, and is for in vitro diagnostic use.
Inquire
Medicine Products: